Net claims of non-residents on India declined by $34.2 billion in Q4 FY25: RBI
New Delhi: Net claims of non-residents on India declined by $34.2 billion during the January-March quarter of FY25 to $330 billion, the RBI data showed on Friday.
Higher rise in Indian residents' overseas financial assets ($60.0 billion) as compared to that in the foreign-owned assets in India ($25.8 billion) led to the decline in net claims of non-residents during the quarter, according to data relating to India's International Investment Position for end-March 2025.
'Increase in reserve assets accounted for over 54 per cent of the rise in Indian residents' overseas financial assets, followed by currency and deposits and direct investments,' the IIP data showed.
Rise in loans ($10.0 billion) and inward direct investment ($9.7 billion) together accounted for over three-fourths of the rise in foreign liabilities of Indian residents during January-March 2025.
Reserve assets accounted for 58.7 per cent of India's international financial assets. The ratio of India's international assets to international liabilities increased to 77.5 per cent in March 2025 from 74.8 per cent a quarter ago.
According to the Central Bank, the share of debt liabilities in total external liabilities increased during the quarter and stood at 54.8 per cent.
During 2024-25, the net claims of non-residents declined by $31.2 billion on the back of higher rise in India's external financial assets ($105.4 billion) vis-a-vis external financial liabilities ($74.2 billion).
Over 72 per cent of the rise in India's overseas financial assets was due to increase in overseas direct investment, currency and deposits, and reserve assets. Inward direct investments, loans as well as currency & deposits accounted for over three-fourths of the rise in foreign liabilities during the year.
The ratio of India's international financial assets to international financial liabilities increased to 77.5 per cent in March 2025 from 74.1 per cent a year ago, the data showed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Torrent Pharma to acquire JB Pharma from KKR at ₹25,689 cr valuation
In one of the largest pharma deals in the domestic market in recent years, Ahmedabad-based Torrent Pharmaceuticals will acquire a controlling stake in investment firm KKR-backed JB Chemicals and Pharmaceuticals (known as JB Pharma) at an equity valuation of ₹25,689 crore, which will be followed by the merger of the two entities. The deal will be executed in two phases — acquisition of the 46.39 per cent stake held by KKR in JB Pharma at ₹1,600 per share, amounting to ₹11,917 crore, followed by a mandatory open offer to acquire up to 26 per cent of JB Pharma shares from public shareholders at ₹1,639.18 per share. 'In addition to the above, Torrent has also expressed its intent to acquire up to 2.8 per cent of equity shares from certain employees of JB Pharma at the same price per share as KKR,' the company said in a statement on Sunday. The next step in the deal will be a merger between Torrent Pharma and JB Pharma through a scheme of arrangement, under which every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent Pharma. The boards of directors of both companies have approved this arrangement. KKR had acquired 54 per cent of JB Pharma in July 2020 from the promoters and founders, the Mody family, for approximately ₹3,100 crore (or ₹745 per share). It sold a part of its stake in March this year through block deals for ₹1,459.8 crore. KKR has earned more than five times on its investment, with around 36 per cent gross IRR. For instance, Torrent Pharma has previously indicated plans to increase its medical representative (MR) strength by 23 per cent by the end of FY26, and the acquisition can aid in manpower augmentation. Torrent Pharma holds a 3.74 per cent share in the domestic market (according to Pharmarack, May 2025), while JB Pharma commands a 1.12 per cent share. Further, consolidation in key international markets is expected to offer greater scalability. Samir Mehta, executive chairman of Torrent Pharma, said they want to build on JB Pharma's heritage and platform for the future. 'Torrent's deep India presence and JB Pharma's fast-growing India business, combined with the CDMO and international footprint, offer immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market and builds a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.' Torrent has previously taken the inorganic route to grow its business and enter newer segments — in 2013, it acquired Elder Pharma's India-branded business; followed by the dermaceutical business of Zyg Pharma in 2015 and the API plant of Glochem Industries in 2016. Among other major deals, it bought the India-branded business of Unichem in 2017. Its last major acquisition was of skin-care products from Curatio Healthcare in 2022. Torrent Pharma is a highly domestic-focused company, drawing around 55 per cent of its consolidated revenues from the domestic formulations business. India sales grew by 13 per cent in FY25 to ₹6,393 crore. While the company has been outperforming industry growth in the domestic market, it is also planning to increase MR strength by 23 per cent by FY26-end. Torrent has a strong presence in the cardiovascular, gastrointestinal and neurology segments. JB too has prominent cardiac and gastro brands like Cilacar, Metrogyl and Rantac. Torrent is also working on launching GLP-1 products as a day-one launch in FY26. Analysts expect a 15 per cent sales CAGR in domestic formulations for Torrent Pharma over FY25–27. Gaurav Trehan, co-head of Asia Pacific and head of Asia Pacific private equity at KKR, and CEO of KKR India, said: 'JB Pharma's transformation under our stewardship is a testament to KKR's ability to scale high-quality companies.' Nikhil Chopra, chief executive officer and whole-time director of JB Pharma, pointed out that over the past five years, the company has emerged as one of India's fastest-growing pharmaceutical players. 'We have built a strong foundation to deliver market-leading growth, as well as consistent improvement in profitability in the medium and long term. As we now enter a new chapter alongside Torrent Pharmaceuticals, we are confident that the combined strengths of our organisations will unlock greater opportunities to enhance healthcare access across our markets,' Chopra said. JB Pharma posted 12 per cent revenue growth in FY25 to ₹3,918 crore, while its EBITDA rose 16 per cent to ₹1,087 crore, and PAT increased 19 per cent to ₹660 crore. Notably, KKR Private equity has invested $2 billion in India in 2024 and recently invested $600 million in Manipal Group via its private credit arm.
&w=3840&q=100)
Business Standard
22 minutes ago
- Business Standard
Contribute to stable borders, Xi tells Tibetans near Arunachal Pradesh
Chinese President Xi Jinping on Sunday called on the Tibetan residents of a village situated near the Indian border to contribute towards fostering prosperity and stability in the border areas. "Learning that the village has undergone new changes in recent years and villagers' incomes have increased, I feel happy for you," Xi replied to a letter received from residents of Nyingchi, a prefecture-level area located close to the Arunachal Pradesh border. China claims Arunachal Pradesh as part of South Tibet, which is firmly rejected by India. Xi visited Nyingchi in 2021, becoming the only Chinese president to have visited the border areas of Tibet. Xi, in his letter, voiced hope that Nyingchi residents will, under the guidance of the Communist Party's policies to develop border areas and improve people's lives, do an even better job in protecting the natural beauty of the plateau region, developing the village's tourist brand, and contributing to building a prosperous and stable border area. In recent years, China has built a number of villages along the Tibetan border areas to ensure border security and development. In his letter, Xi also urged the people in the Tibet Autonomous Region to uphold ethnic solidarity and create a happier and better life, the state-run Xinhua news agency reported. During his 2021 visit to Nyingchi, Xi visited the Nyang River Bridge to inspect the ecological preservation in the basin of the Brahmaputra River, which is called Yarlung Zangbo in the Tibetan language. Last year, China approved the construction of the world's largest dam, stated to be the planet's biggest infrastructure project, costing $137 billion, on the Brahmaputra river in Tibet, which has raised concerns in the riparian states of India and Bangladesh. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Hindustan Times
35 minutes ago
- Hindustan Times
RBI opens vaults: Gold reserves revealed for the first time in documentary series
For the first time, the Reserve Bank of India (RBI) is showing its hidden gold reserve, giving the public a rare look at the gold that supports the country's financial stability. The RBI will offer people a rare glimpse of country's hidden gold reserves.(Representative Image) India's total gold reserves, estimated at over 850 tonnes, is featured in the documentary series RBI Unlocked: Beyond the Rupee, according to a report in Republic. The RBI, in collaboration with JioHotstar, has launched a five-part documentary series to highlight its various functions and roles. The documentary aims to present the essence of the RBI's work in a simple and understandable way for a wider audience. Also Read: Drone rescues man trapped on roof as floods swallow streets in Southern China | Video The documentary has covered the gold bricks, each weighing 12.5 kg, which form part of the country's gold reserves stored in the RBI's vaults in Mumbai and Nagpur. India's current gold reserves are estimated at around 854 tonnes, with 510 tonnes stored domestically and 324 tonnes kept abroad. According to the report, the documentary quotes an RBI official as saying, 'Countries will rise and fall. Economies will have ups and downs. But gold will always maintain its value.' Produced by Chalkboard Entertainment, the documentary traces the RBI's 90-year journey and highlights how it evolved into a full-service monetary authority. Also Read: '477 drones, 60 missiles': What Ukraine says about Russia's massive aerial strike The new series marks a new chapter for the central bank, signalling a shift from its traditionally secretive and opaque approach to a more transparent effort to showcase the nation's wealth and financial stability to its citizens. The RBI carries out a broad range of functions, including currency management, monetary policy formulation, regulation and supervision of banks, and oversight of currency, markets, and payment systems, among other vital responsibilities. It also seeks to build greater public trust by offering insight into the RBI's role in India's economy.
